About
Profile
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
RMD
Recent Earnings
ResMed Non-GAAP EPS of $1.66 beats by $0.04, revenue of $1.03B beats by $33.78M
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- ResMed appoints CEO Michael Farrell as chair of the board
- ResMed Non-GAAP EPS of $1.66 beats by $0.04, revenue of $1.03B beats by $33.78M
- ResMed Q2 2023 Earnings Preview
- ResMed shares fall 6% despite reporting FQ1 2023 revenue growth
- ResMed declares $0.44 dividend
- ResMed Non-GAAP EPS of $1.51 misses by $0.09, revenue of $950.3M beats by $4.39M
- ResMed Q1 2023 Earnings Preview
- ResMed raised to Buy at BofA citing Q1 beat
- ResMed downgraded at JPMorgan and RBC despite earnings beat
- ResMed raises dividend by ~5% to $0.44/share
- ResMed Non-GAAP EPS of $1.49 beats by $0.03, revenue of $914.74M beats by $2.22M
- ResMed Q4 2022 Earnings Preview
- ResMed acquires digital insomnia therapy company mementor to bolster sleep portfolio
- Mehul Joshi joins Berkeley Lights as CFO
- ResMed to acquire German health software company MediFox for ~$1B
- ResMed nears $1B deal to buy health software provider MediFox - Bloomberg
- Amazon, Domino's among additions to BofA's Alpha Surprise screen
- ResMed goes ex-dividend tomorrow
- Starbucks, Meta, Exxon among many stocks dropping off BofA's Alpha Surprise screen
- ResMed Non-GAAP EPS of $1.32 misses by $0.12, revenue of $864.5M misses by $35.53M
Recent Earnings
ResMed Non-GAAP EPS of $1.66 beats by $0.04, revenue of $1.03B beats by $33.78M
Earnings History
Date | EPS / Forecast | Revenue / Forecast | |
---|---|---|---|
April 25, 2018 | - / - | - / 575.8M | |
January 23, 2018 | - / - | - / 515.5M | |
October 26, 2017 | - / - | - / 473.8M | |
August 1, 2017 | - / - | - / 553.9M | |
April 27, 2017 | - / - | - / - | |
January 23, 2017 | - / - | - / 446.7M |
Date | Price | Open | High | Low | Vol | Change | ER | |||
---|---|---|---|---|---|---|---|---|---|---|
Feb 16, 2022 | 33.220 | 33.190 |
33.340
|
32.800
|
1.61M | 2.18% | ||||
Feb 15, 2022 | 32.510 | 32.920 |
32.920
|
32.150
|
1.33M | -4.63% | ||||
Feb 14, 2022 | 34.090 | 34.190 |
34.390
|
33.840
|
903.10K | 0.74% | ||||
Feb 11, 2022 | 33.840 | 33.960 |
34.140
|
33.820
|
754.56K | -0.76% | ||||
Feb 10, 2022 | 34.100 | 34.300 |
34.590
|
34.100
|
788.66K | 0.71% | ||||
Feb 9, 2022 | 33.860 | 33.850 |
34.080
|
33.500
|
895.59K | 1.71% | ||||
Feb 8, 2022 | 33.290 | 33.160 |
33.610
|
33.050
|
846.10K | -0.54% | ||||
Feb 7, 2022 | 33.470 | 33.570 |
34.060
|
33.470
|
1.18M | -0.68% | ||||
Feb 4, 2022 | 33.700 | 33.470 |
33.700
|
33.270
|
1.24M | 1.51% | ||||
Feb 3, 2022 | 33.200 | 32.930 |
33.210
|
32.815
|
1.31M | 1.22% | ||||
Feb 2, 2022 | 32.800 | 32.630 |
32.930
|
32.270
|
1.15M | 0.34% | ||||
Feb 1, 2022 | 32.690 | 32.450 |
32.860
|
32.050
|
1.31M | 2.48% | ||||
Jan 31, 2022 | 31.900 | 32.480 |
32.500
|
31.780
|
1.63M | 2.08% | ||||
Jan 28, 2022 | 31.250 | 31.510 |
31.690
|
30.950
|
3.92M | -0.48% | ||||
Jan 27, 2022 | 31.400 | 32.570 |
32.655
|
31.115
|
2.41M | -3.86% | ||||
Jan 25, 2022 | 32.660 | 33.200 |
33.450
|
32.650
|
1.73M | -0.21% | ||||
Jan 24, 2022 | 32.730 | 32.680 |
32.910
|
32.540
|
1.03M | -0.18% | ||||
Jan 21, 2022 | 32.790 | 33.000 |
33.060
|
32.620
|
982.63K | -1.71% | ||||
Jan 20, 2022 | 33.360 | 33.410 |
33.580
|
33.110
|
825.18K | 0.60% | ||||
Jan 19, 2022 | 33.160 | 33.570 |
33.600
|
33.160
|
878.79K | -4.44% | ||||
Jan 18, 2022 | 34.700 | 34.740 |
35.000
|
34.660
|
784.09K | 0.14% | ||||
Jan 17, 2022 | 34.650 | 34.790 |
34.840
|
34.370
|
603.86K | -0.4% |